Keyphrases
Metabolic Parameters
99%
Adiponectin
98%
Arterial Elasticity
95%
Arterial Compliance
94%
Arterial Stiffness
93%
Elasticity Index
85%
Augmentation Index
80%
Cardiovascular Risk
77%
Large Arteries
76%
Osteoprotegerin
69%
Diabetic Patients
67%
Pulse Wave Velocity
61%
Hypertensive Patients
60%
Small Artery Elasticity
59%
Artery Elasticity
56%
Non-alcoholic Fatty Liver Disease (NAFLD)
55%
Type 2 Diabetic Patients
52%
Hypertension
51%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
48%
Hemoglobin A1c (HbA1c)
48%
Metformin
47%
Vascular Circulation
45%
High Dose
44%
Type 2 Diabetes Mellitus (T2DM)
43%
Small Arteries
42%
Insulin
41%
Left Ventricular Mass
40%
Diabetes
39%
Serum Adiponectin
38%
Inflammatory Parameters
36%
Metformin Treatment
36%
Fetal Vascular
36%
Maternal Vascular
36%
Elasticity Parameters
36%
Postmenopausal Women
35%
Arterial Properties
34%
Postmenopausal Osteoporosis
34%
Long-term Treatment
34%
Angiotensin Receptor Blockers
34%
Left Ventricular Hypertrophy
34%
Treatment Duration
34%
Lipid Profile
33%
Risk Factors
31%
Glucose Homeostasis
31%
Candesartan
29%
Vitamin D Supplementation
28%
Ferritin
28%
Leptin-to-adiponectin Ratio
28%
Diabetic
27%
Aldosterone
25%
Medicine and Dentistry
Adiponectin
88%
Pulse Wave Velocity
76%
Artery Compliance
67%
Arterial Stiffness
64%
Diabetes Mellitus
53%
Body Mass Index
53%
Maturity Onset Diabetes of the Young
49%
Glycon
45%
Homeostatic Model Assessment
44%
Cardiovascular Risk
42%
Diabetes
41%
Nonalcoholic Fatty Liver
39%
Left Ventricular Hypertrophy
34%
Blood Pressure
30%
Placebo
28%
Cardiovascular System
27%
Atherosclerosis
26%
Cardiovascular Disease
24%
Patient with Type 2 Diabetes
24%
Aldosterone
23%
Ferritin
22%
Postmenopause
22%
Rosiglitazone
22%
Family History
22%
Glucose Metabolism
20%
Supplementation
19%
Low Density Lipoprotein Cholesterol
19%
Insulin Resistance
18%
Glucose Homeostasis
18%
Osteoprotegerin
18%
C Reactive Protein
18%
Logistic Regression Analysis
16%
Ossification
16%
Drug Megadose
15%
Renin
15%
Hypercholesterolemia
15%
Homocysteine
15%
Statin
15%
Bone Remodeling
15%
Systolic Blood Pressure
15%
Diastolic Blood Pressure
15%
Impaired Fasting Glucose
14%
Glucose Tolerance
14%
Deterioration
14%
Gestational Diabetes
13%
Amino Terminal Sequence
13%
Biological Marker
13%
Patient with Hypertension
13%
Exercise Intervention
13%
Endothelin
13%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
100%
Diabetes Mellitus
78%
Cardiovascular Risk
62%
Osteoprotegerin
61%
Metformin
57%
Nonalcoholic Fatty Liver
51%
Non Insulin Dependent Diabetes Mellitus
44%
Atherosclerosis
40%
Placebo
40%
Aldosterone
36%
Insulin Resistance
35%
Angiotensin Receptor Antagonist
34%
Ferritin
34%
Leptin
32%
Renin
29%
Candesartan
27%
Angiotensin
25%
Vitamin D
24%
Risedronic Acid
22%
Metabolic Syndrome X
22%
Atorvastatin
22%
Hyperlipidemia
22%
Heart Left Ventricle Hypertrophy
22%
Rosiglitazone
22%
Cardiovascular Disease
22%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Hypercholesterolemia
17%
Low Density Lipoprotein Cholesterol
15%
Homocysteine
15%
Coronary Artery Disease
15%
Vascular Disease
14%
Acetylsalicylic Acid
14%
C Peptide
14%
Endothelin
13%
Antihypertensive Agent
13%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Hemoglobin A1c
12%
Abdominal Obesity
11%
Hip Fracture
11%
Fragility Fracture
11%
Beta Adrenergic Receptor Blocking Agent
11%
Ascorbic Acid
11%
Low Density Lipoprotein
11%
Diabetic Obesity
11%
Levothyroxine
11%
Subclinical Hyperthyroidism
11%
Humoral Antibody
11%
Calcium Channel Blocker
11%
Mental Diseases
11%
Thyrotropin
11%
